Cargando…
Recurrent Challenges for Clinicians: Emergence of Methicillin-Resistant Staphylococcus aureus, Vancomycin Resistance, and Current Treatment Options
Gram-positive pathogens mainly, Staphylococcus aureus, Enterococcus and coagulase-negative Staphylococcus, are developing increasing resistance to glycopeptides that pose a problem in treating infections caused by these pathogens. Vancomycin is the treatment of choice in treating methicillin-resista...
Autores principales: | Tarai, Bansidhar, Das, Poonam, Kumar, Dilip |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968634/ https://www.ncbi.nlm.nih.gov/pubmed/24701097 http://dx.doi.org/10.4103/0974-2727.119843 |
Ejemplares similares
-
Vancomycin Heteroresistance in Methicillin-resistant Staphylococcus aureus, Taiwan
por: Wang, Jiun-Ling, et al.
Publicado: (2004) -
Methicillin-Susceptible, Vancomycin-Resistant Staphylococcus aureus, Brazil
por: Panesso, Diana, et al.
Publicado: (2015) -
Methicillin and Vancomycin Resistant S. aureus in Hospitalized Patients
por: Loomba, Poonam Sood, et al.
Publicado: (2010) -
Resistance and Molecular Characteristics of Methicillin-Resistant Staphylococcus aureus and Heterogeneous Vancomycin-Intermediate Staphylococcus aureus
por: Liang, Jin, et al.
Publicado: (2023) -
Methicillin-resistant Staphylococcus aureus and Vancomycin-resistant Enterococci Co-colonization
por: Furuno, Jon P., et al.
Publicado: (2005)